Corporate Restatement Announcements (2003)
 
Company Date Reason
Parametric (PMTC) 2-Jan filing delay
QuadraMed (QMDCE) 9-Jan CFO resigns under cloud
Lehman Brothers (LEH) 9-Jan Settlement of research bias allegations
Alaska Air (ALK) 10-Jan Andersen
Applied Extrusion Technologies (AETC) 14-Jan Sale/leaseback accounting
Ariba (ARBA) 15-Jan Failure to record payments and stock options as expenses
HumaTech (HUMT:OTCBB) 16-Jan Revenue
BayCorp Holdings (MWH:Amex) 16-Jan Review by new auditors
Veritas (VRTS) 17-Jan Accounting for software/ad swaps with AOL
Pixelworks (PXLW) 21-Jan Acquisition
Agilent (A) 21-Jan "Reclassifies" results to create new unit
Freddie Mac (FRE) 22-Jan Timing of recognition of income
Gemstar-TV Guide (GMSTE) 23-Jan Revenue recognition
Cambrex (CBM) 24-Jan Expensing
i2 Technologies (ITWO) 27-Jan Andersen
Perrigo (PRGO) 27-Jan Compensation Cost
Carreker (CANIE) 28-Jan Revenue
Glenborough Realty Trust (GLB) 28-Jan Andersen
Anika Therapeutics (ANIK) 28-Jan Revenue recognition
Pro-Fac (preferred) (PFACP) 30-Jan Overstated gain
Commerce One (CMRC) 30-Jan Overstated options expense
Dynegy (DYN) 31-Jan Additional
Todd Shipyards (TOD) 31-Jan Pension settlement
Norstan (NRRD) 3-Feb Andersen
Commerce Bancshares (CBSH) 3-Feb Will start expensing options
D&B (DNB) 5-Feb Revenue recognition
BankAtlantic Corp. (BBX) 6-Feb Improperly accounted for the value of mutual funds in a compensation plan
Qwest (Q) 11-Feb Augments previous restatement; revenue recognition, accounting for optical capacity asset transactions
NCO Group (NCOG) 12-Feb Revenue recognition
Caraco Pharmaceutical (CARA) 12-Feb N/A
Loews (LTR) 13-Feb Goodwill accounting
Symbol Technologies (SBL) 13-Feb Revenue recognition
Dynegy (DYN) 14-Feb Third restatement; related to "forward power curve methodology"
Enzon (ENZN) 18-Feb Writedown of investment in Nektar Therapeutics
First Financial (THFF) 19-Feb Better than originally estimated
Nationwide Financial (NFS) 24-Feb Adverse ruling in lawsuit
Ahold  (AHO) 24-Feb Improper accounting of promotional payments from suppliers
Schering-Plough (SGP) 25-Feb Increased litigation reserves amid federal inquiries into sales, marketing, clinical trials
Ultralife Battery (ULBI) 25-Feb Accounting for sale of stake in Ultralife Taiwan